4CPS-349 Role of hospital pharmacists in oncogeriatric consultations: a retrospective study
Background and importancePopulation aging and the growing risk of developing cancer with age lead to an increasing number of elderly patients treated in the oncology care unit. Elderly people are fragile, polypathological and polymedicated. To optimise their care, oncogeriatric consultations are per...
Saved in:
Published in | European journal of hospital pharmacy. Science and practice Vol. 28; no. Suppl 1; p. A89 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
London
BMJ Publishing Group LTD
01.03.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background and importancePopulation aging and the growing risk of developing cancer with age lead to an increasing number of elderly patients treated in the oncology care unit. Elderly people are fragile, polypathological and polymedicated. To optimise their care, oncogeriatric consultations are performed by a doctor, nurse, dietician and psychologist.Aim and objectivesThe aim of this study was to evaluate the benefit of including the hospital pharmacist in these consultations.Material and methodsA retrospective study was conducted on 17 patient files that had been reviewed in oncogeriatric consultations at our hospital centre from May 2019 to March 2020. We searched for information on each patient in the electronic medical record: medical background, usual treatments, considered cancer therapy, biological results, risk of falling, and the presence of balance and cognitive disorders. We then analysed drug interactions, identified potentially inappropriate prescriptions according to the STOPP and START criteria and the anticholinergic burden of the treatment.ResultsAverage age was 84 and the male/female ratio was 0.55. 62 pharmaceutical interventions could have been transmitted to the doctor if the pharmacist had participated in these consultations (ranging from 3 to 6 interventions per patient, average 3.65). There were 7 types: addition of treatment (21), monitoring to be programmed remotely from the consultation (10), dosage adjustments (7), treatment discontinuation (7), biological monitoring (7), adaptation of the intake plan (6) and molecule switch (4). The main interventions were: management of vitamin deficiencies (D, B9, B12), anti-pneumococcal vaccination, discontinuation of drugs with formal contraindications or belonging to the same therapeutic class, high dose PPIs without indication, benzodiazepines dose adjustment, monitoring of nephrotoxicity and serum potassium, replacement of one benzodiazepine by another with a shorter half-life and adaptation of the intake plan to limit interactions between oral chemotherapy and antacid.Conclusion and relevanceThe pharmacist has a real role to play in oncogeriatric consultations, to prevent iatrogeny and optimise patient care. The limitations of the study were the non-exhaustiveness of the treatment (self-medication and phytotherapy), ignorance of potential swallowing disorders and vaccinations carried out. However, this missing information can impact on patient care and could be collected by the hospital pharmacist.References and/or acknowledgementsConflict of interestNo conflict of interest |
---|---|
AbstractList | Background and importancePopulation aging and the growing risk of developing cancer with age lead to an increasing number of elderly patients treated in the oncology care unit. Elderly people are fragile, polypathological and polymedicated. To optimise their care, oncogeriatric consultations are performed by a doctor, nurse, dietician and psychologist.Aim and objectivesThe aim of this study was to evaluate the benefit of including the hospital pharmacist in these consultations.Material and methodsA retrospective study was conducted on 17 patient files that had been reviewed in oncogeriatric consultations at our hospital centre from May 2019 to March 2020. We searched for information on each patient in the electronic medical record: medical background, usual treatments, considered cancer therapy, biological results, risk of falling, and the presence of balance and cognitive disorders. We then analysed drug interactions, identified potentially inappropriate prescriptions according to the STOPP and START criteria and the anticholinergic burden of the treatment.ResultsAverage age was 84 and the male/female ratio was 0.55. 62 pharmaceutical interventions could have been transmitted to the doctor if the pharmacist had participated in these consultations (ranging from 3 to 6 interventions per patient, average 3.65). There were 7 types: addition of treatment (21), monitoring to be programmed remotely from the consultation (10), dosage adjustments (7), treatment discontinuation (7), biological monitoring (7), adaptation of the intake plan (6) and molecule switch (4). The main interventions were: management of vitamin deficiencies (D, B9, B12), anti-pneumococcal vaccination, discontinuation of drugs with formal contraindications or belonging to the same therapeutic class, high dose PPIs without indication, benzodiazepines dose adjustment, monitoring of nephrotoxicity and serum potassium, replacement of one benzodiazepine by another with a shorter half-life and adaptation of the intake plan to limit interactions between oral chemotherapy and antacid.Conclusion and relevanceThe pharmacist has a real role to play in oncogeriatric consultations, to prevent iatrogeny and optimise patient care. The limitations of the study were the non-exhaustiveness of the treatment (self-medication and phytotherapy), ignorance of potential swallowing disorders and vaccinations carried out. However, this missing information can impact on patient care and could be collected by the hospital pharmacist.References and/or acknowledgementsConflict of interestNo conflict of interest |
Author | Ruppert, L Lelievre, I Mortier, CP Phan, B |
Author_xml | – sequence: 1 givenname: L surname: Ruppert fullname: Ruppert, L organization: Hopital Avranches Granville, Pharmacy, Avranches, France – sequence: 2 givenname: CP surname: Mortier fullname: Mortier, CP organization: Hopital Avranches Granville, Pharmacy, Avranches, France – sequence: 3 givenname: I surname: Lelievre fullname: Lelievre, I organization: Hopital Avranches Granville, Pharmacy, Avranches, France – sequence: 4 givenname: B surname: Phan fullname: Phan, B organization: Hopital Avranches Granville, Pharmacy, Avranches, France |
BookMark | eNo9kMtKAzEYhYNUsNa-Q9D11FwmmYk7Kd6goHhZSsgkGSdlOhmTVOjOjS_qkzi11tX_Lc5_DnzHYNT5zgJwitEMY8rP7bLpGxVWGUEEZ1Y1vfZdPcMlPgBjgvIiE4Lno39m_AhMY3QVYpSWIqdiDF7z-cNTRnPx_fn16FsLfQ0bH3uXVAt_25V2MUXoOug77d9scCoFp-GwFddtUskNcAEVDDaF4dPq5D4sjGltNifgsFZttNO_OwEv11fP89tscX9zN79cZBUmHGd1gbnRdVkUSgtaiFJbqjFFyNRmwKpitMQmNzVHzArOCsIJMqxgFeaCKUMn4GzX2wf_vrYxyaVfh26YlIQhjAXhnAwptktVq6Xsg1upsJEYya1MuZcptzLlXqYcZNIf4AtwZA |
ContentType | Journal Article |
Copyright | Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. 2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. |
Copyright_xml | – notice: Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. |
DBID | 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA BENPR BTHHO CCPQU FYUFA GHDGH K9. PQEST PQQKQ PQUKI PRINS |
DOI | 10.1136/ejhpharm-2021-eahpconf.181 |
DatabaseName | ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central ProQuest Central BMJ Journals ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China |
DatabaseTitle | ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition BMJ Journals ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | ProQuest One Academic Eastern Edition |
Database_xml | – sequence: 1 dbid: 7X7 name: ProQuest_Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2047-9964 |
EndPage | A89 |
GroupedDBID | 0R~ 3V. 53G 7X7 8FI 8FJ AAYAA ABKRM ABUWG ABVAJ ABWEH ADBBV ADMRH AFKRA AHMBA AHQMW AJYBZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BENPR BPHCQ BTHHO C45 CCPQU CXRWF EBS EJD FYUFA H13 HAJ HMCUK HYE OK1 OVD PQQKQ PROAC RHI RMJ RPM TEORI UKHRP 7XB 8FK K9. PQEST PQUKI PRINS |
ID | FETCH-LOGICAL-b1261-f716dcf877ac93798ce3c1300dfdce3bb5381d4df605e96572620d575b1695ad3 |
IEDL.DBID | BENPR |
ISSN | 2047-9956 |
IngestDate | Thu Oct 10 18:42:35 EDT 2024 Wed Aug 21 03:31:58 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Suppl 1 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b1261-f716dcf877ac93798ce3c1300dfdce3bb5381d4df605e96572620d575b1695ad3 |
OpenAccessLink | https://ejhp.bmj.com/content/ejhpharm/28/Suppl_1/A89.1.full.pdf |
PQID | 2501192662 |
PQPubID | 2040966 |
ParticipantIDs | proquest_journals_2501192662 bmj_primary_10_1136_ejhpharm_2021_eahpconf_181 |
PublicationCentury | 2000 |
PublicationDate | 20210300 20210301 |
PublicationDateYYYYMMDD | 2021-03-01 |
PublicationDate_xml | – month: 03 year: 2021 text: 20210300 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | European journal of hospital pharmacy. Science and practice |
PublicationYear | 2021 |
Publisher | BMJ Publishing Group LTD |
Publisher_xml | – name: BMJ Publishing Group LTD |
SSID | ssib053389439 ssj0000605265 ssib018287486 |
Score | 2.2121146 |
Snippet | Background and importancePopulation aging and the growing risk of developing cancer with age lead to an increasing number of elderly patients treated in the... |
SourceID | proquest bmj |
SourceType | Aggregation Database Publisher |
StartPage | A89 |
SubjectTerms | Conflicts of interest Pharmacists |
Title | 4CPS-349 Role of hospital pharmacists in oncogeriatric consultations: a retrospective study |
URI | http://dx.doi.org/10.1136/ejhpharm-2021-eahpconf.181 https://www.proquest.com/docview/2501192662 |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEF6sXryIouKz7MFr2myy2U28iJaWIlikKvQiIfuIVWoS23r34h_1lziTbvQgeAvklG8ms9889htCzqIIRcwD5sU5yzzOA-kpYM4eT3zts0yHUmMd8mYkhg_8ehJNXMFt4cYqm5hYB2pTaqyRd-GoZsBGhAguqjcPt0Zhd9Wt0GiRjYBxbNNuXPVHt-PGo1gt5_4rkAbcBvXGk58qjC9Q7wTnHAOULMBrnk6ZlIWia1-mFQpIgyvB19hsWkGOmncYimC31OvLn_hdH0qDbbLl2CS9XJl_h6zZYpc88t7tnRfy5Ovjc1zOLC1zOnXrQWi1kqoG4y7oc0HLQpdP6IQo1E813secrZrzi3Oa0bldzsvmMiatpWj3yMOgf98bem6LgqcYFpdyyIiMzmMpMw1cJIm1DTU2sUxu4FEpCHnMcJMDFDYRkUSJegMsTjGRRJkJ98l6URb2gNBIhCYTWppQCS7zKImNAMLgZzGk5Er5h6QDqKTVSicjrfOLUKQNjCnCmDYwpgDjITlpAEzdv7NIfy199P_rY7JZG6aeCDsh68v5uz0FirBUbdKSE9l23tCuazjf8ea6kw |
link.rule.ids | 315,786,790,12083,21416,27955,27956,31752,33777,43343,43838,74100,74657 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfZ09T8MwEIYtCgMsCASIbzywpo1rx0lYEEKgAi1C0EpdkBV_hIIgCW3ZWfij_BLu0qQMSGyRMuXucn7vbD9HyHEQIMS8zbwoZYknRDv0NChnT8S-8VlieGiwD9m7lZ2BuB4Gw6rhNqmOVdY5sUzUNjfYI2_BUs1AjUjZPi3ePZwahbur1QiNBlkSnAuM83A4X05ZCXP_xaOBskHaeDzvwfgSaSd4yrGNwAK85FlxSRmXLfcyKhAfDYEE3-KSUQEVatpkiMBu6LeXP9m7XJIu18hqpSXp2cz562TBZRvkUZzfPXhcxN-fX_f5q6N5SkfVcBBazEDV4NoJfc5onpn8CUMQMf3U4G3M19nW_OSEJnTspuO8vopJSxDtJhlcXvTPO141Q8HTDFtLKdRD1qRRGCYGlEgcGccNbmHZ1MKj1pDwmBU2BVO4WAYhAuotaDjNZBwklm-RxSzP3DahgeQ2kSa0XEsRpkEcWQlywU8iKMi19ndIE6yiihklQ5XVBZeqNqNCM6rajArMuEP2awOq6s-ZqF8_7_7_-ogsd_q9rupe3d7skZXSSeXZsH2yOB1_uAMQC1N9WEbED92iuiM |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEF6sgngRRcX63IPX2GyTbBIvItVSn4ha6EWW7MsqmsS23r34R_0lzqQbexC8BXLKN5OZb2ZnvyHkIIpQxLzNvMSyzAvDduxJYM5emPrKZ5kKYoV9yOsb3uuHF4No4Oafxm6sso6JVaDWhcIeeQtSNQM2wnm7Zd1YxO1p97h893CDFJ60unUaDbIAWdLHNQ7x4De1skrYfSaVBiwHlcfT336Mz1H5BCce2yhegBc-nUYpC3jLvAxLlJIGp4LvMtmwhGrVHjKUw27It5c_kbxKT90Vsux4JT2ZOsIqmTP5GnkMO7f3XhCm359fd8WroYWlQ7cohJZT0Wow85g-57TIVfGE7oiS_VThzczX6TH9-IhmdGQmo6K-lkkrUdp10u-ePXR6ntun4EmGbSYLtZFWNonjTAErSRNlAoXHWdpqeJQSgh_TobYAhUl5FKNYvQY-JxlPo0wHG2Q-L3KzSWjEA51xFetA8jC2UZpoDtTBzxIozqX0m-QQUBHlVDFDVJVGwEUNo0AYRQ2jABibZKcGULi_aCxmNt_6__U-WQRnEFfnN5fbZKmyUTUmtkPmJ6MPswu8YSL3Kof4AW59vk8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=4CPS-349%E2%80%85Role+of+hospital+pharmacists+in+oncogeriatric+consultations%3A+a+retrospective+study&rft.jtitle=European+journal+of+hospital+pharmacy.+Science+and+practice&rft.au=Ruppert%2C+L&rft.au=Mortier%2C+CP&rft.au=Lelievre%2C+I&rft.au=Phan%2C+B&rft.date=2021-03-01&rft.issn=2047-9956&rft.eissn=2047-9964&rft.volume=28&rft.issue=Suppl+1&rft.spage=A89&rft.epage=A89&rft_id=info:doi/10.1136%2Fejhpharm-2021-eahpconf.181&rft.externalDBID=ttps%3A%2F%2Fejhp.bmj.com%2Fcontent%2F28%2FSuppl_1%2FA89.1.full.pdf |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2047-9956&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2047-9956&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2047-9956&client=summon |